Notify me when Rhenman & Partners Asset Management AB files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 94 | $1,069,994,013 | +$253,327,319 | -$204,581,949 | +$48,745,370 | REGN, LLY, BSX, MDT, ISRG | 13F-HR | 13 Feb 2026, 06:05 |
| Q3 2025 | 92 | $903,668,707 | +$237,181,184 | -$155,089,494 | +$82,091,690 | BSX, LLY, ABBV, DHR, ALHC | 13F-HR | 13 Nov 2025, 06:32 |
| Q2 2025 | 90 | $791,015,290 | +$146,358,238 | -$221,606,005 | -$75,247,767 | LLY, BSX, VRTX, GKOS, ISRG | 13F-HR | 13 Aug 2025, 06:18 |
| Q1 2025 | 94 | $869,997,756 | +$164,653,838 | -$271,365,466 | -$106,711,628 | UNH, LLY, VRTX, MCK, BSX | 13F-HR | 14 May 2025, 07:00 |
| Q4 2024 | 92 | $972,945,612 | +$100,170,008 | -$237,010,647 | -$136,840,639 | BSX, LLY, PRCT, ISRG, REGN | 13F-HR | 13 Feb 2025, 06:16 |
| Q3 2024 | 95 | $1,232,086,076 | +$247,263,584 | -$141,464,877 | +$105,798,707 | BSX, UNH, LLY, REGN, THC | 13F-HR | 13 Nov 2024, 06:10 |
| Q2 2024 | 93 | $1,041,575,267 | +$183,894,529 | -$172,550,097 | +$11,344,432 | UNH, ELV, BSX, LLY, REGN | 13F-HR | 13 Aug 2024, 07:00 |
| Q1 2024 | 84 | $1,055,081,207 | +$265,135,670 | -$324,503,481 | -$59,367,811 | CI, LLY, THC, BSX, ELV | 13F-HR | 14 May 2024, 06:09 |
| Q4 2023 | 85 | $1,001,010,596 | +$185,737,167 | -$215,780,145 | -$30,042,978 | MDT, LLY, BSX, VRTX, REGN | 13F-HR | 13 Feb 2024, 09:24 |
| Q3 2023 | 85 | $927,505,090 | +$106,194,772 | -$64,129,814 | +$42,064,958 | LLY, BSX, BMRN, REGN, MCK | Restatement | 13 Nov 2023, 06:08 |
| Q2 2023 | 83 | $948,682,403 | +$195,289,292 | -$225,333,080 | -$30,043,788 | LLY, BMRN, CI, BSX, MCK | 13F-HR | 11 Aug 2023, 06:10 |
| Q1 2023 | 88 | $909,268,485 | +$144,903,940 | -$164,120,516 | -$19,216,576 | LILLY ELI & CO, UNH, BSX, REGN, VRTX | 13F-HR | 11 May 2023, 18:57 |
| Q4 2022 | 93 | $958,473,386 | +$98,842,782 | -$92,002,973 | +$6,839,809 | LLY, COR, MDT, BSX, REGN | 13F-HR | 13 Feb 2023, 06:26 |
| Q3 2022 | 90 | $862,672,000 | +$129,885,864 | -$111,589,488 | +$18,296,376 | LLY, UNH, BSX, VRTX, TMO | 13F-HR | 14 Nov 2022, 16:36 |
| Q2 2022 | 86 | $880,150,000 | +$112,458,935 | -$157,082,919 | -$44,623,984 | CI, LLY, ABBV, UNH, PFE | 13F-HR | 12 Aug 2022, 08:00 |
| Q1 2022 | 89 | $1,013,563,000 | +$78,816,484 | -$511,913,582 | -$433,097,098 | LLY, HZNP, ABBV, UNH, MCK | 13F-HR | 13 May 2022, 16:32 |
| Q4 2021 | 92 | $1,503,868,000 | +$170,107,469 | -$141,555,951 | +$28,551,518 | UNH, PFE, LLY, HZNP, ELV | 13F-HR | 11 Feb 2022, 06:09 |
| Q3 2021 | 92 | $1,424,766,000 | +$197,854,978 | -$172,418,322 | +$25,436,656 | HZNP, UNH, ELV, JNJ, PFE | 13F-HR | 12 Nov 2021, 06:05 |
| Q2 2021 | 94 | $1,473,245,000 | +$219,822,090 | -$244,927,144 | -$25,105,054 | UNH, HZNP, VRTX, JAZZ, ELV | 13F-HR | 13 Aug 2021, 06:12 |
| Q1 2021 | 92 | $1,434,218,000 | +$311,594,083 | -$137,235,844 | +$174,358,239 | HZNP, JNJ, UNH, JAZZ, ABBV | 13F-HR | 14 May 2021, 06:01 |
| Q4 2020 | 83 | $1,225,693,000 | +$231,190,235 | -$265,059,774 | -$33,869,539 | ABBV, BMRN, HZNP, MDT, UNH | 13F-HR | 19 Jan 2021, 10:56 |
| Q3 2020 | 82 | $1,124,651,000 | +$186,760,801 | -$62,359,041 | +$124,401,760 | BMRN, HZNP, NVCR, UNH, VRTX | 13F-HR | 13 Oct 2020, 12:17 |
| Q2 2020 | 94 | $925,638,000 | +$117,428,611 | -$124,835,669 | -$7,407,058 | HZNP, VRTX, UNH, ABBV, BMRN | 13F-HR | 16 Jul 2020, 10:38 |
| Q1 2020 | 85 | $713,821,000 | +$88,522,724 | -$89,907,593 | -$1,384,869 | HZNP, VRTX, ABBV, NVCR, UNH | 13F-HR | 16 Apr 2020, 11:17 |
| Q4 2019 | 94 | $912,515,000 | +$136,508,228 | -$209,828,119 | -$73,319,891 | ESPR, VRTX, NVCR, HZNP, HUM | 13F-HR | 17 Jan 2020, 16:30 |
| Q3 2019 | 93 | $797,699,000 | +$133,679,320 | -$110,208,207 | +$23,471,113 | VRTX, HZNP, NVCR, ALXN, ESPR | 13F-HR | 16 Oct 2019, 06:05 |
| Q2 2019 | 88 | $881,681,000 | +$138,845,664 | -$127,503,301 | +$11,342,363 | VRTX, HUM, JAZZ, ALXN, NKTR | 13F-HR | 22 Jul 2019, 16:38 |
| Q1 2019 | 93 | $854,928,000 | +$114,913,433 | -$224,846,465 | -$109,933,032 | UNH, JAZZ, VRTX, ABMD, CI | 13F-HR | 11 Apr 2019, 06:14 |
| Q4 2018 | 89 | $874,811,000 | +$173,299,311 | -$110,635,568 | +$62,663,743 | UNH, CI, MDT, CVS, BDX | 13F-HR | 05 Feb 2019, 09:55 |
| Q3 2018 | 88 | $997,986,000 | +$109,316,990 | -$179,925,619 | -$70,608,629 | CI, CVS, ALXN, VRTX, INCY | 13F-HR | 03 Oct 2018, 07:33 |
| Q2 2018 | 89 | $977,105,000 | +$229,495,349 | -$89,047,849 | +$140,447,500 | NKTR, HZNP, VRTX, INCY, ABMD | 13F-HR | 20 Jul 2018, 09:42 |
| Q1 2018 | 92 | $811,255,000 | +$163,190,599 | -$125,198,052 | +$37,992,547 | HZNP, CELG, ALXN, VRTX, JAZZ | 13F-HR | 11 Apr 2018, 09:56 |
| Q4 2017 | 95 | $740,066,000 | +$114,829,654 | -$213,692,015 | -$98,862,361 | HZNP, ESPR, ADMS, EXEL, VRTX | 13F-HR | 19 Jan 2018, 16:10 |
| Q3 2017 | 94 | $783,338,000 | +$195,456,515 | -$153,519,882 | +$41,936,633 | HZNP, VRTX, EXEL, ABMD, ALXN | 13F-HR | 13 Oct 2017, 17:02 |
| Q2 2017 | 108 | $696,477,000 | +$155,905,623 | -$117,841,483 | +$38,064,140 | HZNP, EXEL, NVCR, ALXN, CELG | 13F-HR | 11 Jul 2017, 09:02 |
| Q1 2017 | 104 | $631,470,000 | +$140,563,551 | -$95,739,924 | +$44,823,627 | HZNP, ESPR, BIIB, GKOS, AMGN | 13F-HR | 19 Apr 2017, 09:51 |
| Q4 2016 | 108 | $521,630,000 | +$116,102,978 | -$159,940,675 | -$43,837,697 | GILD, BMY, AGN, LLY, MDT | 13F-HR | 13 Jan 2017, 09:05 |
| Q3 2016 | 107 | $603,016,922 | +$147,763,120 | -$156,561,338 | -$8,798,218 | LLY, ALXN, CELG, Pfizer Inc, AGN | 13F-HR | 08 Nov 2016, 08:37 |
| Q2 2016 | 97 | $563,148,000 | +$128,988,671 | -$86,676,021 | +$42,312,650 | ALXN, GILD, CELG, BIIB, LLY | 13F-HR | 01 Aug 2016, 11:22 |
| Q1 2016 | 92 | $503,761,000 | +$89,946,990 | -$154,324,002 | -$64,377,012 | ALXN, GILD, BMRN, PFE, LLY | 13F-HR | 19 Apr 2016, 06:51 |
| Q4 2015 | 96 | $661,398,000 | +$114,201,010 | -$122,330,680 | -$8,129,670 | PRGO, ABMD, MDT, ALXN, CVS | 13F-HR | 19 Jan 2016, 10:13 |
| Q3 2015 | 91 | $627,273,000 | +$174,739,428 | -$153,433,631 | +$21,305,797 | AMGN, ALXN, MDT, UNH, LLY | 13F-HR | 26 Oct 2015, 09:44 |
| Q2 2015 | 94 | $706,819,000 | +$195,446,086 | -$77,741,378 | +$117,704,708 | UNH, ALXN, ALKS, BIIB, CVS | 13F-HR | 30 Jul 2015, 09:55 |
| Q1 2015 | 88 | $561,172,000 | +$231,835,436 | -$51,337,430 | +$180,498,006 | ALXN, CELG, MRK, BIIB, AMGN | 13F-HR | 13 May 2015, 08:07 |
| Q4 2014 | 84 | $335,903,000 | +$94,072,160 | -$144,561,511 | -$50,489,351 | CELG, GILD, CVS, REGN, ABBV | 13F-HR | 09 Feb 2015, 08:16 |
| Q3 2014 | 99 | $324,264,000 | +$79,845,626 | -$101,579,485 | -$21,733,859 | ALKS, UHS, ALXN, BIIB, SLXP | 13F-HR | 03 Nov 2014, 11:30 |
| Q2 2014 | 96 | $337,007,000 | +$98,402,422 | -$85,486,071 | +$12,916,351 | BIIB, F113PS, GILD, ALXN, CELG | 13F-HR | 31 Jul 2014, 10:46 |
| Q1 2014 | 90 | $300,005,000 | +$114,275,661 | -$51,027,586 | +$63,248,075 | GILD, ALXN, REGN, BIIB, PFE | 13F-HR | 14 May 2014, 09:22 |
| Q4 2013 | 83 | $251,079,000 | $0 | $0 | $0 | REGN, CELG, GILD, CVS, BIIB | 13F-HR | 14 Feb 2014, 10:39 |